Northeast Georgia Heart Center (NGHC) has collaborated with Northeast Georgia Medical Center (NGMC) to complete a coronary angioplasty with a help of a robot. This robotic-assisted angioplasty is performed as a part of the CorPath PRECISE clinical test.
Percutaneous coronary interventions surgical room
The CorPath clinical trial will test the efficiency and safety of the CorPath 200 system in providing and controlling coronary stents and guide wires in percutaneous coronary interventions (PCI) therapeutic procedures.
The CorPath 200 system offers accurate, placement of coronary stents, angioplasty balloons, and guide wires from an easy and comfortable interventional cockpit with the help of a robot. The person who operates the system is shielded in a lead insulated cockpit to prevent exposure to harmful radiation. The ergonomic seating arrangement offers clear vision of the angiography display, thereby minimizing tiredness and pain in the back, neck, and head.
The robotic-assisted angioplasty has several benefits over a traditional PCI technique. A person who performs the traditional PCI therapy is exposed to substantial amounts of radiation. This exposure can be reduced by using a robot. With further advancements in the PCI procedures in the near future, the utilization of robots in PCI surgical procedures can offer greater support and industrious hands to carry out the complicated procedures.